Literature DB >> 31184495

A constructive critique of the draft ICH E9 Addendum.

Daniel O Scharfstein1.   

Abstract

In this article, I review the key elements of the proposed International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use E9 Addendum, present a constructive critique, and provide recommendations of how it can be improved. To highlight ideas, I present a case study involving a confirmatory trial for a chronic pain medication.

Entities:  

Keywords:  Estimand; intention-to-treat; pain; sensitivity analysis; treatment strategy

Mesh:

Year:  2019        PMID: 31184495     DOI: 10.1177/1740774519853566

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  3 in total

1.  Implementation of ICH E9 (R1): A Few Points Learned During the COVID-19 Pandemic.

Authors:  Yongming Qu; Ilya Lipkovich
Journal:  Ther Innov Regul Sci       Date:  2021-05-13       Impact factor: 1.337

2.  Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.

Authors:  Marian Mitroiu; Steven Teerenstra; Katrien Oude Rengerink; Frank Pétavy; Kit C B Roes
Journal:  Pharm Stat       Date:  2022-06-09       Impact factor: 1.234

3.  The factors associated with nosocomial infection in elderly hip fracture patients: gender, age, and comorbidity.

Authors:  Yuan Deng; Zhong Zheng; Shi Cheng; Yuan Lin; Duanyang Wang; Pengbin Yin; Zhi Mao; Peifu Tang
Journal:  Int Orthop       Date:  2021-08-05       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.